Subjective features of the psilocybin experience that may account for its self-administration by humans: a double-blind comparison of psilocybin and dextromethorphan
Carbonaro, T. M., Johnson, M. W., & Griffiths, R. R | Psychopharmacology | 5 June 2020
Psilocybin: from ancient magic to modern medicine
Nichols, D. E. | The Journal of Antibiotics | 12 May 2020
Long-term Follow-Up Outcomes of MDMA-assisted Psychotherapy for Treatment of PTSD: A Longitudinal Pooled Analysis of Six Phase 2 Trials
Jerome, L., Feduccia, A. A., Wang, J. B., Hamilton, S., Yazar-Klosinski, B., Emerson, A., ... & Doblin, R. | Psychopharmacology | 11 May 2020
Can Psychedelics Alleviate Symptoms of Cluster Headache and Accompanying Mental Health Problems? A Case Report Involving Hawaiian Baby Woodrose
Johnson, S., & Black, Q. C. | Journal of Psychoactive Drugs | 7 May 2020
Psilocybin and LSD Have No Long-Lasting Effects in an Animal Model of Alcohol Relapse
Meinhardt, M. W., Güngör, C., Skorodumov, I., Mertens, L. J., & Spanagel, R. | Neuropsychopharmacology | 5 May 2020
Chronic pain and psychedelics: a review and proposed mechanism of action
Castellanos, J. P., Woolley, C., Bruno, K. A., Zeidan, F., Halberstadt, A., & Furnish, T. | Regional Anesthesia & Pain Medicine | 4 May 2020